Peptide CDMO Market, Global Outlook and Forecast 2023-2030
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
This report aims to provide a comprehensive presentation of the global market for Peptide CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CDMO. This report contains market size and forecasts of Peptide CDMO in global, including the following market information:
Global Peptide CDMO Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Peptide CDMO market was valued at US$ 2369.9 million in 2022 and is projected to reach US$ 6096.1 million by 2029, at a CAGR of 14.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Bachem is the largest player of global peptide CDMO market, holds a share over 20%, other key players include PolyPeptide, AmbioPharm, and USV Peptides, etc. In terms of type, APIs and intermediates type is the largest segment, with a share about 60%, and in terms of application, the commercial segment holds share about 80 percent.
We surveyed the Peptide CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide CDMO Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Peptide CDMO Market Segment Percentages, by Type, 2022 (%)
LPPS
SPPS
Mixed Phase
Global Peptide CDMO Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Peptide CDMO Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Industry
Cosmetics Industry
Others
Global Peptide CDMO Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Peptide CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptide CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Pharma
PolyPeptide
Bachem
ScinoPharm
CBL
AmbioPharm
Piramal Pharma
CordenPharma
CPC SCIENTIFIC
Provepharm
Space Peptides
Biopeptek
Alpha Biophama
Alabiochem
Aurigene Pharmaceutical Services
Chengdu Shengnuo Biotechnology Co., Ltd
Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide CDMO, market overview.
Chapter 2: Global Peptide CDMO market size in revenue.
Chapter 3: Detailed analysis of Peptide CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
